Jonathan Davis
The notebook this week lists the 20 trusts that made up the original 20-trust portfolio that I wrote about last week. I also add a series of short notes and links across a variety of topics. In this week's Q and A I talk to Stephanie Sirota, a director of RTW Ventures, a recently launched trust that invests in medicines, biotech and medical technology. It is not a trust that I own myself (it does not meet enough of my criteria), but it has performed spectacularly since its launch in 2019 and operates in what is clearly potentially a very high growth area.
PRS REIT
I am pleased ...
This is a premium article for our subscribers.
Please log in below to read it, or find out how to join the Money Makers Circle.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.